‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights

[ad_1] There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world — or … Read More

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. … Read More